Norgestimate And Ethinyl Estradiol
Product Images NDC 50090-3733

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 50090-3733). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-b (Figure B)

Figure-b (Figure B)
FDA Label Image

Figure-c (Figure C)

Figure-c (Figure C)
Norgestimate and Ethinyl Estradiol Tablets USP are available in three different strengths: 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg. The package is not child-resistant, so it is important to keep this and all medications out of children's reach. There is also a Figure C present, but it is not described or referenced, so its purpose is unknown.*
FDA Label Image

Figure-d (Figure D)

Figure-d (Figure D)
FDA Label Image

Figure-e (Figure E)

Figure-e (Figure E)
FDA Label Image

Pill-dispenser (Image 01)

Pill-dispenser (Image 01)
FDA Label Image

Img3 (Img3)

Img3 (Img3)
This text appears to be a chart or graphic displaying various methods of birth control and their effectiveness at preventing pregnancy. The chart lists different methods of birth control including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, and natural family planning methods like avoiding sex during the most fertile days of the cycle, using spermicide, and withdrawal. The chart also includes ranges of pregnancy rates per 100 women in one year with some methods having fewer pregnancies with less than 1 pregnancy per 100 women in one year, 10 to 20 pregnancies per 100 women in one year for some methods, and 85 or more pregnancies per 100 women in one year for those choosing not to use any birth control.*
FDA Label Image

Label Image (Lbl500903733)

Label Image (Lbl500903733)
FDA Label Image

Logo-1 (Logo 1)

Logo-1 (Logo 1)
This is only a proper noun, referring to the company Glenmark. Without further context, it is not possible to provide a useful description.*
FDA Label Image
Logo (Logo)
The text is limited to a single letter and a company name, "Glenmark". It may refer to the Indian pharmaceutical company Glenmark Pharmaceuticals Limited. However, without additional context, it is impossible to provide a useful description.*
FDA Label Image

Pill-dispenser (Pill Dispenser 01)

Pill-dispenser (Pill Dispenser 01)
Norgestimate and Ethinyl Estradiol Tablets USP are available in three variants that differ in the amount of the two active ingredients present. These tablets are color-coded based on their type and are meant to be taken on specific days of the week. The white to off-white, light blue, and blue pills are active, while the green to dark green pills are inactive. However, this package is not child-resistant, and caution should be exercised to keep it out of the reach of children.*
FDA Label Image

Structures (Structures)

Structures (Structures)
Ethinyl estradiol USP is a pharmacological substance that is commonly used in hormonal contraceptives. It is a synthetic form of estrogen that is used in combination with other hormones, such as progestin, to prevent pregnancy by inhibiting ovulation. Ethinyl estradiol USP is also used to treat other hormonal imbalances, such as menopausal symptoms and acne.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.